Latest Monoclonal Antibody Treatment Approved for High-Risk Patients May 27, 2021 Auto Bot antibodies, Coronavirus (2019-nCoV), Food and Drug Administration, GlaxoSmithKline PLC 0 The drug, from GlaxoSmithKline and Vir, aims to keep those who have contracted the disease out of the hospital.